Tech Company Financing Transactions
Reviva Pharmaceuticals Funding Round
Reviva Pharmaceuticals, operating out of Sunnyvale, received $4.8 million in funding from private investors.
Transaction Overview
Company Name
Announced On
5/24/2017
Transaction Type
Debt
Amount
$4,800,000
Round
Undisclosed
Investors
private investors (Lead Investor)
private investors (Purav Patel)
Proceeds Purpose
As we continue to execute on our business strategy, this capital will enable us to complete our ongoing preparations for next set of clinical trials of the company's lead drug candidate RP5063 and provides us with the flexibility to pursue certain near-term financing options.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1250 Oakmead Pkwy. 210
Sunnyvale, CA 94085
USA
Sunnyvale, CA 94085
USA
Phone
Website
Email Address
Overview
Reviva Pharmaceuticals Inc, a privately held, clinical stage pharmaceutical company, is developing a portfolio of internally discovered therapies that address unmet medical needs in the areas of central nervous system (CNS), metabolic, and cardiopulmonary diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Laxminarayan Bhat
Chief Financial Officer
Narayan Prabhu
Chief Medical Officer
Marc Cantillon
Browse more venture capital transactions:
Prev: 5/24/2017: Long Game venture capital transaction
Next: 5/24/2017: G2 Crowd venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs